REMS For Opioids, LABAs May Be Driven By PBM "Feedback" Mechanism
This article was originally published in The Pink Sheet Daily
Executive Summary
Possible contract from FDA would involve assessing whether PBM distribution of safety information to physicians would change prescribing practices.